Psychometric Validation of the SF-36 Health Survey in Ulcerative Colitis: Results from a Systematic Literature Review
Overview
Rehabilitation Medicine
Authors
Affiliations
Purpose: To conduct a systematic literature review of the reliability, construct validity, and responsiveness of the SF-36 Health Survey (SF-36) in patients with ulcerative colitis (UC).
Methods: We performed a systematic search of electronic medical databases to identify published peer-reviewed studies which reported scores from the eight scales and/or two summary measures of the SF-36 collected from adult patients with UC. Study findings relevant to reliability, construct validity, and responsiveness were reviewed.
Results: Data were extracted and summarized from 43 articles meeting inclusion criteria. Convergent validity was supported by findings that 83% (197/236) of correlations between SF-36 scales and measures of disease symptoms, disease activity, and functioning exceeded the prespecified threshold (r ≥ |0.40|). Known-groups validity was supported by findings of clinically meaningful differences in SF-36 scores between subgroups of patients when classified by disease activity (i.e., active versus inactive), symptom status, and comorbidity status. Responsiveness was supported by findings of clinically meaningful changes in SF-36 scores following treatment in non-comparative trials, and by meaningfully larger improvements in SF-36 scores in treatment arms relative to controls in randomized controlled trials. The sole study of SF-36 reliability found evidence supporting internal consistency (Cronbach's α ≥ 0.70) for all SF-36 scales and test-retest reliability (intraclass correlation coefficient ≥0.70) for six of eight scales.
Conclusions: Evidence from this systematic literature review indicates that the SF-36 is reliable, valid, and responsive when used with UC patients, supporting the inclusion of the SF-36 as an endpoint in clinical trials for this patient population.
Quality of Life of Caregivers of Patients with Cancer: A Cross-Sectional Study.
Alghamdi W, Almatrafi M, Asiri R, Almuraee L, Alsharif S, Makhdoum F Healthcare (Basel). 2025; 13(5).
PMID: 40077083 PMC: 11899707. DOI: 10.3390/healthcare13050521.
Bato A, Brodszky V, Rencz F Health Qual Life Outcomes. 2025; 23(1):14.
PMID: 39962594 PMC: 11831779. DOI: 10.1186/s12955-025-02343-5.
The Short Form 6 Dimensions (SF-6D): Development and Evolution.
Mukuria C, Rowen D, Mulhern B, McDool E, Kharroubi S, Bjorner J Appl Health Econ Health Policy. 2024; 23(1):19-33.
PMID: 39460886 PMC: 11729076. DOI: 10.1007/s40258-024-00919-8.
Erol Dogan O, Karaca Celik K, Bas M, Alan E, Cagin Y Nutrients. 2024; 16(10).
PMID: 38794742 PMC: 11123867. DOI: 10.3390/nu16101504.
Fedorchuk C, Fedorchuk C, Lightstone D J Clin Med. 2024; 13(7).
PMID: 38610790 PMC: 11012333. DOI: 10.3390/jcm13072024.